Skip to content
ED Philippines

Editorial policy

Our rules on sources, Philippine prescription drug advertising rules, generic-first naming, no dosing advice, corrections and independence from providers.

Short answer

We write to educate, not to sell. Every page is sourced, dated and written to follow the Philippine rules on prescription medicines: generic names first, no sales language, no dosing instructions. Errors are corrected openly, and no brand, pharmacy or telehealth provider can pay to change what we say.

Medically reviewed by Pending: licensed PH physicianLast reviewed

What sources do we use?

Primary sources first. In rough order of preference:

  1. Philippine regulators: FDA Philippines advisories and product registrations, the Professional Regulation Commission, the Department of Health and the National Privacy Commission.
  2. Clinical guidelines from professional bodies, such as the American Urological Association and the European Association of Urology.
  3. Approved product information and drug labels.
  4. Peer-reviewed studies, cited individually on PubMed.
  5. Reputable patient-information services such as MedlinePlus, the NHS and major academic hospitals.

Pharmacy websites and suggested retail price pages are used for prices only, never for clinical claims. Forums, seller pages and social media posts are never cited as evidence. Every page lists at least three sources at the bottom, each with a working link. The full standard is on our sources and methodology page.

How do we follow Philippine rules on prescription medicines?

Sildenafil, tadalafil and dapoxetine are prescription medicines in the Philippines. Two sets of rules shape how we write about them.

  • Administrative Order No. 65 (1989) of the Department of Health sets rules on the advertising and promotion of medicines under the Generics Act. Among other things, it restricts the advertising of prescription drugs to the public through mass media and requires the generic name to be prominent.
  • FDA Advisory No. 2022-0108 is the FDA Philippines advisory our compliance rules are built around, alongside AO 65. More broadly, the FDA has repeatedly reminded companies and the public that prescription drug products may not be promoted or advertised to the general public, including on online selling platforms and social media.

We are not a manufacturer, distributor or seller, and we do not advertise any product. To stay clearly on the side of education, we apply these rules to ourselves anyway:

  • Education only. Pages explain what a medicine is, how it works, who should not use it, what it is listed at and how to get a prescription. They do not encourage anyone to use a particular product.
  • No sales language. We never write "buy", "order", "shop", "promo" or "discount" near the name of a medicine or brand, and we never publish promo codes.
  • Calls to action are about doctors. The only button on the site is about talking to a licensed doctor, never about getting a drug.
  • Prices are information. Listed prices are shown with the pharmacy, date and source so readers can see what things cost; see the prices page. We do not rank products by which one to choose.

Why do we name the generic first?

The Generics Act of 1988 puts the generic name at the centre of how medicines are prescribed and labelled in the Philippines, and it is the name that tells you what is actually in the tablet. So we always write the generic name first and the brand in brackets: sildenafil (Viagra), tadalafil (Cialis). Headings and tables lead with the generic. Brand pages, such as our Spiagra page, state the generic in the first line.

Why is there no dosing advice?

Because the right strength and frequency depend on your health, your other medicines and your doctor's assessment. Pages may list the strengths a medicine is registered in (for example, sildenafil comes in 25, 50 and 100 mg tablets). They never say how much to use, when or how often. That is always decided by your doctor.

What else do we never publish?

  • Links to marketplace sellers, kamagra sellers or "herbal" products that may contain undeclared drugs. We describe the risk, never the route.
  • Claims that any supplement treats ED or PE.
  • Words that overstate results, such as promises of certainty or claims that a medicine is risk-free. Every medicine has side effects.
  • Images of people, couples or bodies, sexual language or innuendo.
  • Nightlife, dating or party framing on expat and city pages.

How do we stay independent from providers?

The site's consultation button routes to a partner telehealth service, and the site may be paid for referrals in future (see our about page). To keep that from shaping content:

  • Telehealth providers and clinics are compared on published, neutral criteria (consult fee, prices, delivery, consult type, date checked), and partners get no special treatment in tables or text.
  • No provider, pharmacy or brand reviews or approves our pages before publication.
  • We do not accept payment for coverage, rankings, removals or "sponsored" articles.
  • The medical reviewer never endorses a brand or provider.

How do corrections work?

If we get something wrong, we fix it and say so.

  1. Send the page address and the problem to us through our contact page.
  2. Safety-related errors (for example a missing warning) are fixed first, ahead of everything else. Other factual errors are fixed as soon as we have checked them against the sources.
  3. A substantive correction adds a dated note at the bottom of the page saying what changed. Typos and broken links are fixed without a note.
  4. If a correction affects clinical content, the page goes back to the medical reviewer.

Who writes the pages?

Pages are written and edited by our editorial team against an internal style and compliance guide, then checked by the medical reviewer described on the medical review page. Automated checks run before every update to catch banned phrases, hand-typed prices, sales words near drug names and links to blocked sellers.

Want an answer for your own situation? Talk to a licensed doctor online. It is private, and the doctor decides what, if anything, suits you.

Sources

  1. 1.Republic Act No. 6675: Generics Act of 1988. Lawphil (Arellano Law Foundation).
  2. 2.Republic Act No. 7394: Consumer Act of the Philippines. Lawphil (Arellano Law Foundation).
  3. 3.Republic Act No. 9711: Food and Drug Administration Act of 2009. Lawphil (Arellano Law Foundation).
  4. 4.Food and Drug Administration Philippines. FDA Philippines.
  5. 5.Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals. International Committee of Medical Journal Editors.

This site is for education only and is not medical advice: diagnosis and treatment, including whether a medicine is right for you and how much to take, are decided by a licensed doctor.

Talk to a licensed doctor online